AN2 Therapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from AN2 Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 12, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 13, 2025

Earnings release8-K

Quarterly report10-Q

Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 12, 2025

Transcript

2024

Q4 2024

Mar 25, 2025

Annual report10-K

Earnings release8-K

Q3 2024

Nov 13, 2024

Earnings release8-K

Q2 2024

Aug 13, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 14, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 28, 2024

Earnings release8-K

Q3 2023

Nov 9, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 10, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 11, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 29, 2023

Earnings release8-K

Q3 2022

Nov 9, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 11, 2022

Quarterly report10-Q

Earnings release8-K

Q1 2022

May 10, 2022

Quarterly report10-Q

Earnings release8-K